Daewon Pharmaceutical Co., Ltd. (KRX:003220)

Daewon Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 15, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	242,841	305,427	331,930	393,197	342,999	380,715
Market Cap Growth	-20.21%	-7.99%	-15.58%	14.64%	-9.91%	13.65%
Enterprise Value	395,721	434,054	418,509	453,068	412,231	412,859
Last Close Price	11330.00	14250.00	15327.52	17998.08	15224.81	16689.90
PE Ratio	-	21.49	13.88	12.31	49.08	21.58
Forward PE	69.30	12.63	12.63	12.63	12.63	12.63
PS Ratio	0.41	0.51	0.63	0.82	0.97	1.23
PB Ratio	0.92	1.07	1.26	1.58	1.57	1.79
P/TBV Ratio	1.22	1.27	1.37	1.74	1.77	1.88
P/FCF Ratio	14.00	-	8.41	21.36	18.73	27.98
P/OCF Ratio	5.67	10.17	6.42	14.89	15.30	15.26
PEG Ratio	1.77	0.49	0.49	0.49	0.49	0.49
EV/Sales Ratio	0.67	0.73	0.79	0.95	1.16	1.34
EV/EBITDA Ratio	16.98	9.28	8.40	7.28	11.11	10.41
EV/EBIT Ratio	-	16.27	12.98	10.56	21.36	17.22
EV/FCF Ratio	22.81	-	10.61	24.62	22.52	30.35
Debt / Equity Ratio	0.81	0.66	0.55	0.47	0.57	0.25
Debt / EBITDA Ratio	9.67	4.00	2.93	1.87	3.34	1.32
Debt / FCF Ratio	12.30	-	3.70	6.33	6.77	3.86
Asset Turnover	0.98	1.10	1.10	1.09	0.93	0.93
Inventory Turnover	2.97	2.86	2.76	3.01	2.69	2.49
Quick Ratio	0.64	0.62	0.56	0.89	1.07	0.93
Current Ratio	1.12	1.19	1.15	1.62	1.77	2.09
Return on Equity (ROE)	-6.75%	3.68%	9.15%	13.13%	3.07%	8.25%
Return on Assets (ROA)	-0.04%	3.06%	4.19%	6.07%	3.16%	4.52%
Return on Capital (ROIC)	-0.05%	3.78%	5.20%	7.58%	3.97%	5.76%
Return on Capital Employed (ROCE)	-0.10%	7.00%	9.90%	13.20%	5.90%	8.60%
Earnings Yield	-6.60%	4.65%	7.21%	8.12%	2.04%	4.63%
FCF Yield	7.15%	-1.58%	11.88%	4.68%	5.34%	3.57%
Dividend Yield	2.64%	2.10%	-	-	1.27%	0.93%
Payout Ratio	-	44.75%	30.69%	12.90%	44.93%	28.54%
Buyback Yield / Dilution	1.14%	-1.47%	0.98%	-3.09%	0.58%	1.06%
Total Shareholder Return	3.78%	0.63%	0.98%	-3.09%	1.85%	1.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.